Becton, Dickinson and Company (VIE:BDX)
Austria · Delayed Price · Currency is EUR | Market Cap | 38.11B -37.7% |
| Revenue (ttm) | 18.67B +6.2% |
| Net Income | 1.50B +1.7% |
| EPS | 5.22 +3.1% |
| Shares Out | n/a |
| PE Ratio | 25.47 |
| Forward PE | 12.19 |
| Dividend | 3.61 (2.66%) |
| Ex-Dividend Date | Mar 10, 2026 |
| Volume | 30 |
| Average Volume | 2 |
| Open | 134.80 |
| Previous Close | 134.65 |
| Day's Range | 134.50 - 135.50 |
| 52-Week Range | 132.00 - 209.20 |
| Beta | n/a |
| RSI | 32.23 |
| Earnings Date | Apr 30, 2026 |
About VIE:BDX
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. It operates through Medical Essentials, Connected Care, BioPharma Systems, Interventional and Life Sciences segments. It provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, va... [Read more]
Financial Performance
In fiscal year 2025, VIE:BDX's revenue was $21.84 billion, an increase of 8.24% compared to the previous year's $20.18 billion. Earnings were $1.68 billion, a decrease of -1.58%.
Financial numbers in USD Financial StatementsNews
BD Launches AI-Enabled Medication Dispensing System to the European Market
Advanced automation and connected data capabilities strengthen medication inventory control and enhance safety across pharmacy settings. FRANKLIN LAKES, N.J.
BD Pioneers New Standard in Surgical Safety with FDA-Cleared Surgiphor™ 1000mL for Wound Irrigation
The first and only innovation of its kind to receive 510(k) clearance, Surgiphor™ 1000mL empowers surgical teams with a consistent, antimicrobial solution designed to improve patient care and operatin...
Becton, Dickinson and Company Announces Pricing of the Tender Offers and Amounts Accepted for Purchase
FRANKLIN LAKES, N.J., Feb. 25, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX) (the "Company" or "BD"), a leading global medical technology company, today announced the considerati...
Becton, Dickinson and Company Announces Early Tender Results and Upsizing of Offer SubCap and Aggregate Offer Cap
FRANKLIN LAKES, N.J., Feb. 25, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX) (the "Company" or "BD"), a leading global medical technology company, today announced the early tende...
BD to Present at Barclays 28th Annual Global Healthcare Conference
FRANKLIN LAKES, N.J., Feb. 23, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the Barclays 28...
BD Expands Testing Capabilities to Help Clinicians Improve Diagnostic Accuracy and Efficiency
The BD Vacutainer® Urine Complete Cup Kit preserves specimen quality, streamlines testing, and helps reduce repeat collections to support better patient care FRANKLIN LAKES, N.J., Feb. 23, 2026 /PRNew...
Lanesha Minnix Named General Counsel for BD
FRANKLIN LAKES, N.J., Feb. 19, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Lanesha Minnix has been named exec...
What's Going On With Becton Dickinson Stock Tuesday?
The company reported sales of $5.25 billion, slightly above the consensus of $5.15 billion.
Becton, Dickinson and Company Announces Tender Offers for Outstanding Debt Securities
FRANKLIN LAKES, N.J., Feb. 10, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX) (the "Company" or "BD"), a leading global medical technology company, today announced that it has com...
Dow Falls 250 Points; Becton Dickinson Posts Upbeat Earnings
Becton Dickinson and Co. (NYSE:BDX) on Monday reported upbeat earnings for the first quarter.
Becton Dickinson cuts annual profit forecast to reflect sale of biosciences and diagnostics unit
Medical device maker Becton Dickinson cut its profit forecast for fiscal year 2026 on Monday, adjusting its outlook to account for the separation and sale of its biosciences and diagnostics unit to la...
BD Completes Combination of Biosciences & Diagnostic Solutions Business with Waters Corporation
FRANKLIN LAKES, N.J., Feb. 9, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX) today announced the successful completion of the previously announced spin-off of BD's Biosciences & D...
Waters Completes Combination with BD's Biosciences & Diagnostic Solutions Businesses
Announces appointment of Claire M. Fraser, Ph.D.
BD Reports First Quarter Fiscal 2026 Financial Results
Revenue of $5.3 billion increased 1.6% as reported, 0.4% FXN New BD revenue increased 2.5% FXN GAAP and adjusted diluted EPS of $1.34 and $2.91, respectively Combination of BD's Biosciences and Diagno...
How To Earn $500 A Month From Becton Dickinson Stock Ahead Of Q1 Earnings
Becton Dickinson and Company (NYSE: BDX) will release earnings for its first quarter before the opening bell on Monday, Feb. 9.
BD and Envetec Demonstrate Closed-Loop Recycling Solution for Laboratory Plastics in Health Care
Study Opens Door to Sustainable Path for Polystyrene Petri Dishes, PET Tubes, Medical Tubing, and Polypropylene Syringes Across Healthcare Supply Chains FRANKLIN LAKES, N.J. and BIRDHILL, Colo.
BD Board Declares Dividend, Authorizes 10 Million Additional Share Repurchases; BD Completed $250 Million Repurchase to Date in FY26
FRANKLIN LAKES, N.J., Jan. 27, 2026 /PRNewswire/ -- The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has declar...
BD to Announce Financial Results for its First Quarter of Fiscal 2026
FRANKLIN LAKES, N.J., Jan. 27, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that BD management will host an audio w...
BD Announces Record Date for the Spin-Off of its Biosciences & Diagnostic Solutions Business
Distribution date and closing date for spin-off and merger with Waters Corporation set for February 9, 2026 FRANKLIN LAKES, N.J., Jan. 27, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE...
Waters Shareholders Approve Combination with BD's Biosciences & Diagnostic Solutions Business
Waters Corporation's Q4 2025 Financial Results Conference Call will now be held on Monday, February 9th, 2026 at 8:30am ET in conjunction with the expected close of the transaction MILFORD, Mass., Ja...
BD Helps Scientists Advance Immunology and Cancer Research with AI-Powered Insights and Automation
Newest version of BD® Research Cloud features an AI-powered tool for automated panel design to improve quality, efficiency and usability of scientific results across research areas FRANKLIN LAKES, N.J...
BD and Ypsomed Expand Partnership to Address Rapidly Growing Biologics Market
The enhanced collaboration and innovation will improve options for pharmaceutical companies and patients requiring large-volume self-injection systems LE PONT-DE-CLAIX, France and BURGDORF, Switzerlan...
Becton, Dickinson Wins FDA Clearance For Next-Gen Breast Biopsy Device, Launch Set For 2026
The U.S. Food and Drug Administration on Thursday granted 510(k) clearance for Becton, Dickinson and Company's (NYSE: BDX) new breast biopsy system.
BD Receives FDA 510(k) Clearance for EnCor EnCompass™ Breast Biopsy and Tissue Removal System
State-of-the-art, multi-modality breast biopsy system slated to be in the market in early 2026 FRANKLIN LAKES, N.J., Jan. 15, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a lea...
BD Names Shawn Bevec as Senior Vice President of Investor Relations
FRANKLIN LAKES, N.J., Jan. 14, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Shawn Bevec has been named senior ...